83 Chapter 4 Table 1 (continued) Patient (text ID) EPI/ADP Fibrinogen PT Extem- CT ExtemCFT ExtemMCF ExtemML IntemCT IntemCFT IntemMCF IntemML 1 132/107 3 1.1 75 93 64 5 167 92 62 6 2 295/177 2.4 1 68 100 59 208 98 58 3 (Patient 5) 157/90 3.1 1.1 64 60 63 16 162 52 61 17 4 114/78 4.2 1 49 68 71 6 195 87 68 5 5 (Patient 6) 91/77 2.2 1.1 77 154 52 14 154 130 50 15 6 (Patient 1) 93/102 3 1 64 100 60 7 150 76 60 9 7 123/107 3.4 1 61 92 61 12 129 61 63 13 8 2.9 1 66 70 67 10 171 64 63 10 9 152/109 3.3 1 68 67 64 6 175 70 62 7 10 (Patient 2) 131/124 2.1 1 54 83 59 8 139 70 60 9 11 (Patient 3 3.8 1 60 46 73 8 149 43 71 7 12 112/95 2.9 1.1 72 63 66 6 172 59 64 10 13 119/113 3.2 1 79 76 67 6 195 60 65 8 14 170/92 3 1 55 77 64 5 163 62 63 5 15 168/112 2.6 1 63 66 64 11 163 51 65 11 16 95/76 2.9 1 63 71 68 3 153 68 65 4 17 128/95 2.5 1.1 67 59 70 1 187 52 70 2 18 137/109 4.2 1.1 74 118 60 8 139 96 59 8 19 (Patient 4) 103/84 2.1 1 71 97 58 3 178 107 56 4 20 129/105 3.4 1 55 71 67 2 150 50 69 3 21 95/84 3.4 1 56 59 73 4 169 48 70 10 22 162/158 2.4 1 63 58 68 4 164 53 66 5 Abbreviations: aPTT, activated partial thromboplastin time; BS, bleeding score; CFT, clot formation time; CT, clotting time; EPI/ADP, epinephrine/adenosine diphosphate; Extem, screening test for the extrinsic haemostasis system; F, female; FVII, factor VIII; EIntem, screening test for the haemostasis system; M, male; MCF, maximum clot firmness; ML, maximum lysis; OI, Osteogenesis Imperfecta; PT, prothrombin time; VWF, von Willebrand factor. *Treatment not known, †Without associated gastrointestinal disease, ‡Treated with re-suturing and packing.
RkJQdWJsaXNoZXIy MTk4NDMw